TSLA, HIMS, GLD — Short-Term Pullbacks, Long-Term Signals
TSLA up 4% today but we’re not out of the correction yet.
$420 support could flip to resistance, and the volume profile gap still points to a possible move to $350.
Thesis hasn’t changed.
Long-term bullish, but worst case is still a pullback to $350.
2. $Hims & Hers Health Inc.(HIMS)$
HIMS long-term bull cycle is DONE 🩸
Monthly BX flipped red in October. A clear sign big money is exiting on the higher timeframe.
Over the past 6 years this strategy gave 3 long setups:
🔥 67% win rate
🚀 +240% avg bull cycle
🎯 11.8 R/R
I’m not touching $HIMS until the Monthly BX turns back up.
Likely sells off toward $30 before a real bottom forms.
GLD needs to bounce this week ❌
If the weekly Bx closes red we should see a more significant retracement.
So far, our call out was the top. Now to see if it stays that way
For SG users only, a tool to boost your purchasing power and trading ideas with a Cash Boost Account!
Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here.
Complete your first Cash Boost Account trade with a trade amount of ≥ SGD 5000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.
Other helpful links:
💰Join the TB Contra Telegram Group to Get $10 Trading Vouchers Now🎉
How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
